CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$4,681,915
-16.7%
859,067
+2.5%
0.00%
-50.0%
Q2 2023$5,622,242
-22.7%
837,890
+1.8%
0.00%0.0%
Q1 2023$7,269,907
+15.4%
823,319
-0.1%
0.00%0.0%
Q4 2022$6,298,408
+10.8%
824,399
+3.3%
0.00%0.0%
Q3 2022$5,685,000
-35.7%
798,347
-27.0%
0.00%
-33.3%
Q2 2022$8,848,000
-25.9%
1,093,618
+27.2%
0.00%
-25.0%
Q1 2022$11,934,000
-49.4%
859,768
+2.3%
0.00%
-42.9%
Q4 2021$23,589,000
-15.5%
840,671
+2.3%
0.01%
-22.2%
Q3 2021$27,927,000
+9.2%
821,620
+31.3%
0.01%
+12.5%
Q2 2021$25,573,000
+5.3%
625,869
+3.7%
0.01%
-11.1%
Q1 2021$24,290,000
-25.5%
603,307
+9.4%
0.01%
-30.8%
Q4 2020$32,606,000
+24.0%
551,426
+2.0%
0.01%
+8.3%
Q3 2020$26,302,000
+242.8%
540,851
+241.1%
0.01%
+200.0%
Q2 2020$7,672,000
+88.7%
158,562
+8.3%
0.00%
+100.0%
Q1 2020$4,066,000
+47.9%
146,356
+59.3%
0.00%
+100.0%
Q4 2019$2,750,000
-1.3%
91,896
+2.0%
0.00%
-50.0%
Q3 2019$2,785,00090,1010.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2020
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders